Related content

Applying Proteomics in Clinical Trials: Assessing the Potential and Practical Limitations in Ovarian Cancer

By Tchabo Nana E.   Liel Meghan S.   Kohn Elise C.  

American Journal of PharmacoGenomics, Vol. 5, Iss. 3, 2005-01 ,pp. : 141-148

Adis International

Access to resources Recommend Favorite

Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review

By Kosikowska Paulina   Berlicki ŁŁukasz  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 6, 2011-06 ,pp. : 945-957

Informa Healthcare

Access to resources Recommend Favorite

Carcinoma in situ of the Urinary Bladder: Review of Clinicopathologic Characteristics with an Emphasis on Aspects Related to Molecular Diagnostic Techniques and Prognosis

By Nese Nalan   Gupta Ruta   Bui Matthew H. T.   Amin Mahul B.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 1, 2009-01 ,pp. : 48-57

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Integrins as novel drug discovery targets: potential therapeutic and diagnostic implications

By Mousa S.A.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 2, 2000-04 ,pp. : 143-153

Informa Healthcare

Access to resources Recommend Favorite